ABT
Abbott Laboratories
$123.62
-$1.05(-0.84%)
68
Overall
95
Value
45
Tech
65
Quality
Market Cap
$220.36B
Volume
7.05M
52W Range
$110.86 - $141.23
Target Price
$146.29
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $20.4B | $20.9B | $27.4B | $30.6B | $31.9B | $34.6B | $43.1B | $43.7B | $40.1B | $42.0B | ||
| Total Revenue | $20.4B | $20.9B | $27.4B | $30.6B | $31.9B | $34.6B | $43.1B | $43.7B | $40.1B | $42.0B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $8.7B | $9.0B | $12.4B | $12.7B | $13.2B | $15.0B | $18.5B | $19.1B | $18.0B | $18.7B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $11.7B | $11.8B | $15.0B | $17.9B | $18.7B | $19.6B | $24.5B | $24.5B | $22.1B | $23.2B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $8.2B | $8.1B | $11.4B | $12.0B | $12.2B | $12.1B | $16.1B | $16.1B | $15.7B | $16.4B | ||
| Research & Development | $1.4B | $1.4B | $2.3B | $2.3B | $2.4B | $2.4B | $2.7B | $2.9B | $2.7B | $2.8B | ||
| Research Expense | $1.4B | $1.4B | $2.3B | $2.3B | $2.4B | $2.4B | $2.7B | $2.9B | $2.7B | $2.8B | ||
| Selling, General & Administrative | $6.8B | $6.7B | $9.2B | $9.7B | $9.8B | $9.7B | $11.3B | $11.2B | $10.9B | $11.7B | ||
| General & Administrative Expenses | $6.8B | $6.7B | $9.2B | $9.7B | $9.8B | $9.7B | $11.3B | $11.2B | $10.9B | $11.7B | ||
| Salaries & Wages | -- | -- | -- | -- | $-197.0M | $-200.0M | $-267.0M | $685.0M | $644.0M | -- | ||
| Depreciation & Amortization | $871.0M | $803.0M | $1.0B | $1.1B | $1.1B | $1.2B | $2.0B | $2.0B | $2.0B | $1.9B | ||
| Depreciation & Amortization | $871.0M | $803.0M | $1.0B | $1.1B | $1.1B | $1.2B | $2.0B | $2.0B | $2.0B | $1.9B | ||
| Amortization | $9.6B | $7.7B | $24.0B | $23.3B | $23.2B | $23.7B | $2.0B | $2.0B | $2.0B | $1.9B | ||
| Other Operating Expenses | $-234.0M | $-145.0M | $-187.0M | $-164.0M | $-137.0M | $-190.0M | $-143.0M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $2.9B | $3.2B | $1.6B | $3.6B | $4.5B | $5.4B | $8.4B | $8.4B | $6.5B | $6.8B | ||
| EBITDA | $4.8B | $3.4B | $7.1B | $7.0B | $7.8B | $8.8B | $12.3B | $12.1B | $10.5B | $10.8B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $163.0M | $431.0M | $904.0M | $826.0M | $670.0M | $546.0M | $533.0M | $558.0M | $637.0M | $559.0M | ||
| Intinc | $105.0M | $99.0M | $124.0M | $105.0M | $94.0M | $46.0M | $43.0M | $183.0M | $385.0M | $344.0M | ||
| Net Non-Operating Interest Income/Expense | $-58.0M | $-332.0M | $-780.0M | $-721.0M | $-576.0M | $-500.0M | $-490.0M | $-375.0M | $-252.0M | $-215.0M | ||
| Gain on Sale of Securities | -- | $-947.0M | $45.0M | $50.0M | -- | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $-281.0M | $945.0M | $-1.4B | $28.0M | $-128.0M | $-103.0M | $-277.0M | $319.0M | $-479.0M | $-376.0M | ||
| Other Special Charges | $281.0M | $-945.0M | $1.4B | $-28.0M | $128.0M | $103.0M | $277.0M | $321.0M | $479.0M | $376.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-1.4B | $-1.4B | -- | -- | $66.0M | $36.0M | -- | -- | -- | -- | ||
| Special Income Charges | $1.4B | $1.4B | -- | -- | $-66.0M | $-36.0M | -- | -- | -- | -- | ||
| Other Impairment Of Capital Assets | -- | $947.0M | -- | -- | -- | $115.0M | $55.0M | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $3.3B | $1.8B | $3.1B | $3.7B | $4.7B | $5.5B | $8.7B | $8.9B | $7.3B | $7.6B | ||
| Pre-Tax Income | $3.2B | $1.4B | $2.2B | $2.9B | $4.1B | $5.0B | $8.2B | $8.3B | $6.7B | $7.0B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $577.0M | $350.0M | $1.9B | $539.0M | $390.0M | $497.0M | $1.1B | $1.4B | $941.0M | $-6.4B | ||
| NET INCOME | ||||||||||||
| Net Income | $4.4B | $1.4B | $477.0M | $2.4B | $3.7B | $4.5B | $7.1B | $6.9B | $5.7B | $13.4B | ||
| Net Income (Continuing Operations) | $4.4B | $1.4B | $477.0M | $2.4B | $3.7B | $4.5B | $7.1B | $6.9B | $5.7B | $13.4B | ||
| Net Income (Discontinued Operations) | $4.4B | $1.4B | $477.0M | $2.4B | $3.7B | $4.5B | $7.1B | $6.9B | $5.7B | $13.4B | ||
| Net Income (Common Stockholders) | $5.6B | $2.5B | $4.4B | $6.7B | $7.6B | $4.5B | $7.1B | $6.9B | $5.7B | $13.4B | ||
| Normalized Income | $715.0M | $893.5M | $287.1M | $2.3B | $3.3B | $4.0B | -- | -- | -- | -- | ||
| TOTALS | ||||||||||||
| Total Expenses | $16.9B | $17.1B | $23.9B | $24.8B | $25.4B | $27.1B | $34.6B | $35.3B | $33.6B | $35.1B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $1.5B | $1.5B | $1.7B | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | $1.7B | $1.7B | ||
| Average Shares Outstanding (Diluted) | $1.5B | $1.5B | $1.7B | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | $1.7B | $1.7B | ||
| Shares Outstanding | $1.5B | $1.7B | $1.7B | $1.8B | $1.8B | $1.8B | $1.8B | $1.7B | $1.7B | $1.7B | ||
| Basic EPS | $2.94 | $0.94 | $0.27 | $1.34 | $2.07 | $2.52 | $3.97 | $3.94 | $3.28 | $7.67 | ||
| Basic EPS (Continuing Operations) | $1.73 | $0.71 | $0.20 | $1.32 | $2.07 | $2.51 | $3.97 | $3.94 | $3.28 | $7.67 | ||
| Diluted EPS | $2.92 | $0.94 | $0.27 | $1.33 | $2.06 | $2.5 | $3.94 | $3.91 | $3.26 | $7.64 | ||
| Diluted EPS (Continuing Operations) | $1.72 | $0.71 | $0.20 | $1.31 | $2.06 | $2.49 | $3.94 | $3.91 | $3.26 | $7.64 | ||
| Dividend Per Share | -- | -- | -- | -- | -- | -- | -- | $1.88 | $2.04 | $2.24 | ||
| OTHER METRICS | ||||||||||||
| Basic Discontinuous Operations | $1.21 | $0.23 | $0.07 | $0.02 | -- | $0.01 | -- | -- | -- | -- | ||
| Diluted Discontinuous Operations | $1.2 | $0.23 | $0.07 | $0.02 | -- | $0.01 | -- | -- | -- | -- | ||
| Earnings from equity interest | $207.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | $207.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of Business | -- | $25.0M | $1.2B | -- | -- | -- | -- | -- | -- | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | $1.8B | $16.0M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | $21.3B | $20.7B | $31.1B | $30.7B | $31.3B | $33.0B | -- | -- | -- | -- | ||
| Net Income Discontinuous Operations | $1.8B | $337.0M | $124.0M | $34.0M | -- | $24.0M | -- | -- | -- | -- | ||
| Other Gain Loss From Disposition Of Discontinued Operations | $65.0M | $321.0M | $124.0M | $34.0M | -- | $24.0M | -- | -- | -- | -- | ||
| Other Gand A | $6.8B | $6.7B | $9.2B | $9.7B | $9.8B | $9.7B | $11.3B | $11.2B | $10.9B | $11.7B | ||
| Other Write Off | -- | -- | -- | -- | -- | $35.0M | $26.0M | -- | -- | -- | ||
| Restruct | $-1.4B | $-1.4B | -- | -- | $66.0M | $36.0M | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABT | $123.62 | -0.8% | 7.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |